SCR-LIP-000573 · Claim · machine-readable JSON →
In this review, lipedema patients show a metabolic paradox (frequent BMI ≥30 but preserved insulin sensitivity, normal blood pressure, no hepatic steatosis, normal adiponectin/leptin/CRP) and a LOWER incidence of type 2 diabetes compared with BMI-matched female controls, attributed to a 'protective' effect of gluteofemoral subcutaneous fat deposition.
This single-paper claim was consolidated into general propositions (R-CLM-19); its evidence now sits under:
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- very low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 0 question(s)
- Dates
- 2026-11-17 → 2026-11-17
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17
Evidence over time
Evidence (1)
- Lipedema: A Disease Triggered by M2 Polarized Macrophages? (2025) ✓ verified — consistent · review · 2025 · reading confidence: high
“Diabetes tipo 2: incidência MENOR em pacientes com lipedema vs. controles femininos BMI-matched — efeito 'protetor' da deposição adiposa subcutânea gluteofemoral”
The review explicitly reports lower type 2 diabetes incidence and a favorable metabolic profile in lipedema despite high BMI, describing the gluteofemoral fat deposition as 'protective' — directly affirmative to the question regarding metab
Context (PECO)
Answers these questions
- Not yet linked to a question.
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-11-17 — created · auto-ingested for SQ-LIP-000010
- 2026-11-20 — consolidated · SQ-LIP-000010: evidence moved to SCR-LIP-000628